4//SEC Filing
Kalofonos Isabel 4
Accession 0000950170-25-004855
CIK 0001658247other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:30 PM ET
Size
5.4 KB
Accession
0000950170-25-004855
Insider Transaction Report
Form 4
Kalofonos Isabel
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-10+100,000→ 100,000 totalExercise: $40.59Exp: 2035-01-09→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as follows: 25% of the shares subject to the option vest on December 16, 2025, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001975163
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:30 PM ET
- Size
- 5.4 KB